title: When clinical trials fail to address treatment gaps: the failure of niacin-laropiprant to reduce cardiovascular events.
authors.affiliation: Icahn School of Medicine, Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029, USA. robert.rosenson@mssm.edu
authors.forename: Robert S
authors.initials: RS
authors.lastname: Rosenson
authors.forename: Antonio M
authors.initials: AM
authors.lastname: Gotto
mesh_terms: D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced*; D009525:Niacin / Q000008:administration & dosage*
chemical_list: D000960:Hypolipidemic Agents; D007211:Indoles; C518174:MK-0524; D009525:Niacin